Coherus BioSciences - 53 Year Dividend History | CHRS
Historical dividend payout and yield for Coherus BioSciences (CHRS) since 1971. The current TTM dividend payout for Coherus BioSciences (CHRS) as of December 20, 2024 is $0.00. The current dividend yield for Coherus BioSciences as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.185B |
$0.257B |
|
Coherus Biosciences, Inc. is a biologics platform company developing biosimilar therapeutics. Its clinical stage pipeline consists of CHS-0214 in two Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis; CHS-1420 that has completed a Phase I study to treat psoriasis or rheumatoid arthritis; and CHS-1701 which has completed a Phase I study for the treatment of breast cancer patients. Coherus Biosciences, Inc. is headquartered in Redwood City, California.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
